January 2020

The Clarendon portfolio Neurovalens behind the headset developed to treat neurological health issues has been chosen for a major UK-wide programme. Neurovalens is one of 30 firms around the UK which has been selected for government body Tech Nation’s Upscale 5.0 programme, which supports fast-growing tech companies. The company’s Modius headset aims to treat neurological […]

Clarendon Portfolio company Fusion Antibodies a clinical research firm has reported a strong revenue performance during the third quarter. In a trading update on Wednesday, the publicly listed company said it expects revenues for the year ending March 31 2020 to be significantly ahead of current market expectations, and above the previous year (£2.2 million).

Clarendon portfolio company Thrive a Belfast based provider of employee communications software and support, has secured strategic investment to help facilitate its plans to grow users fourfold to one million by 2022. The company is also initially creating 10 new jobs in marketing, software development, and customer care. Thrive provides software and support to make

Eleven fast growing businesses have secured £2m of funding from HBAN (Halo Business Angel Network) Ulster Business Angels during its first year of operation in Northern Ireland. HBAN is a joint initiative of Invest Northern Ireland, InterTradeIreland and Enterprise Ireland, dedicated to the all-island promotion of business angel investment. HBAN allows companies from a wide